Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
HealthEquity's 10-Year ROIIC % for the quarter that ended in Jan. 2026 was 8.22%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for HealthEquity's 10-Year ROIIC % or its related term are showing as below:
FRA:2HE's 10-Year ROIIC % is ranked better than 63.66% of 487
companies
in the Healthcare Providers & Services industry
Industry Median: 3.4
vs FRA:2HE: 8.22
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
HealthEquity 10-Year ROIIC % Related Terms
HealthEquity 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for HealthEquity's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2HE vs TEM, TXG, HNGE: 10-Year ROIIC % Comparison
For the Health Information Services subindustry, HealthEquity's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity 10-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where HealthEquity's 10-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
HealthEquity (FRA:2HE) has a 10-Year ROIIC % of 8.22 as of Jan. 2026. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on HealthEquity and its competitors. According to the industry distribution chart, HealthEquity ranks #177 out of 487 companies in the Healthcare Providers & Services industry, placing it in the top 36.3%.
Is HealthEquity's 10-Year ROIIC % too high?
HealthEquity's current 10-Year ROIIC % is 8.22. The Healthcare Providers & Services industry median 10-Year ROIIC % is 3.40. HealthEquity's value of 8.22 is 141.8% above this industry median. Based on the distribution chart, HealthEquity ranks #177 out of 487 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, HealthEquity has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's 10-Year ROIIC % compare to TEM and TXG?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #177 out of 487 companies for 10-Year ROIIC %. This puts HealthEquity in the upper half of its industry. The industry median 10-Year ROIIC % is 3.40. HealthEquity's value of 8.22 is 141.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Healthcare Providers & Services company?
The median 10-Year ROIIC % among Healthcare Providers & Services companies is 3.40, based on 487 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current 10-Year ROIIC % of 8.22 is 141.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median 10-Year ROIIC % is 3.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current 10-Year ROIIC % is 8.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current 10-Year ROIIC % of 8.22. The stock's GF Value™ is €86.84, compared to a current price of €87.00 — trading 0.2% above its estimated fair value. The current 10-Year ROIIC % is 8.22 and 141.8% above the Healthcare Providers & Services industry median of 3.40. HealthEquity's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current 10-Year ROIIC % is 8.22 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be overvalued.
The current stock price of €87.00 is trading 0.2% above its estimated GF Value™ of €86.84.
Key valuation signals for FRA:2HE:
10-Year ROIIC %: 8.22
GF Value™: €86.84 vs. price of €87.00 (0.2% above fair value)
Industry Position: 141.8% above the Healthcare Providers & Services median (#177 of 487)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
95GF Score
Get the complete analysis for FRA:2HE
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
